✦ LIBER ✦

Bevacizumab: the first anti-angiogenic agent approved for the treatment of metastatic breast cancer

✍ Scribed by Richard Bell; David Cameron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in the first-line treatment

✍ David Cameron 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Bevacizumab in the Treatment of Metastat

✍ Cianfrocca, Mary; Gradishar, William J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The potential of anti-vascular endotheli

✍ Michel Marty; Xavier Pivot 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Adding bevacizumab to paclitaxel in the

✍ Kevin R. Fox 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 186 KB

Optimal strategies for the treatment of

✍ Andre, F.; Zielinski, C. C. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 114 KB

Bevacizumab, a humanized anti-angiogenic

✍ I. Krämer; H.-P. Lipp 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB